Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Neurana enrols first patient in Phase II trial of tolperisone

Tolperisone is being studied as a relaxant for the relief of pain due to muscle spasm. Credit: Photo by rawpixel on Unsplash.

  • Neurana Pharmaceuticals

Go Top